Form 8-K - Current report:
SEC Accession No. 0001193125-24-227949
Filing Date
2024-09-27
Accepted
2024-09-27 16:05:28
Documents
2
Period of Report
2024-09-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d890673d8k.htm 8-K 21580
2 EX-10.1 d890673dex101.htm EX-10.1 284671
  Complete submission text file 0001193125-24-227949.txt   307447
Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Filer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42279 | Film No.: 241334870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)